Tag Archives: TaSP

Microbicides and other ARV-based prevention: Biomedical answers meet challenges on the ground

By on .

Does adherence to using a product intended to prevent HIV acquisition depend on willingness, or ability to use the product? What are the factors — whether thoughts, beliefs, structural obstacles or social barriers — influencing both? The challenges that women have faced since the recognition of HIV in protecting themselves from getting the virus by […]

AVAC: HIV vaccine, microbicides, PrEP trial results say reality must guide research

By on .

For all the graphics illustrating results of HIV prevention trials in recent years, the Venn diagram on the cover of Research & Reality, the report released by AVAC today, may be the one that depicts the sum of their findings. Which is really saying something, when one considers the up-and-down nature of prevention research results […]

Report shows U.S. HIV research investment, progress; projects lasting impact from cuts

By on .

With the United States funding 70 percent of the world’s research and development of biomedical answers to HIV prevention, progress that has yielded the potential for immediate advances against the global epidemic is in danger of stalling, with lasting consequences, according to a report released at the International AIDS Society conference in Kuala Lumpur this […]

Studies show “Real World,” benefits of HIV treatment: It reduces likelihood of HIV transmission in communities, ups overall life expectancy

By on .

First the landmark HPTN 052 study proved what antiretroviral treatment can do to prevent transmission of HIV. Now, two studies reported in the most recent edition of the journal Science spell out what increased treatment coverage has done, in communities in the “real world” — among people going about their business, not receiving instructions of […]

Blueprint: Use proven methods, research, determination to reach end of epidemic

By on .

Dr. Rochelle Walensky has been a member of the Cost-effectiveness of Preventing AIDS Complications (CEPAC) team since 1998. She is a member of the Office of AIDS Research Advisory Council at the National Institutes of Health and the Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents.  Dr. Walensky has […]

Focus, inclusion, aspiration and language highlight changes in 2013 PEPFAR Country Operational Plan Guidance

By on .

What a difference a year can make, when sometime within that year a goal comes into focus. Every year the President’s Emergency Plan For AIDS Relief puts together a set of guidelines — a Guidance — on how to turn Country Operational Plans into the realities of setting, reaching and documenting goals to put epidemic-fighting […]

Thai trial yield continues with news vaccine changed virus

By on .

The vaccine that showed a vaccine can prevent HIV infection also has shown that the vaccine changed the virus in people who did become infected, according to research revealed today in the first plenary session of AIDS Vaccine 2012. The findings were the third revelation from a study that first generated excitement in the AIDS […]